Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - October 26, 2023 Category: Cancer & Oncology Authors: Tae Min Kim Nicolas Girard Natasha B Leighl Joshua Sabari Nora Rahhali Claudio A Schioppa Joris Diels Jan Sermon Conor Chandler Venediktos Kapetanakis Ruhee Jain Tracy Li Suzy Van Sanden Source Type: research